|
1
|
Touat M, Idbaih A, Sanson M and Ligon KL:
Glioblastoma targeted therapy: Updated approaches from recent
biological insights. Ann Oncol. 28:1457–1472. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gao M, Lin Y, Liu X, Li Y, Zhang C, Wang
Z, Wang Z, Wang Y and Guo Z: ISG20 promotes local tumor immunity
and contributes to poor survival in human glioma. Oncoimmunology.
8(e1534038)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang X, Wang X, Xu R, Ji J, Xu Y, Han M,
Wei Y, Huang B, Chen A, Zhang Q, et al: YM155 decreases
radiation-induced invasion and reverses epithelial-mesenchymal
transition by targeting STAT3 in glioblastoma. J Transl Med.
16(79)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ostrom QT, Gittleman H, Liao P,
Vecchione-Koval T, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2010-2014. Neuro
Oncol. 19 (Suppl 5):v1–v88. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fleischmann DF, Jenn J, Corradini S, Ruf
V, Herms J, Forbrig R, Unterrainer M, Thon N, Kreth FW, Belka C and
Niyazi M: Bevacizumab reduces toxicity of reirradiation in
recurrent high-grade glioma. Radiother Oncol. 138:99–105.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lara-Velazquez M, Al-Kharboosh R,
Jeanneret S, Vazquez-Ramos C, Mahato D, Tavanaiepour D, Rahmathulla
G and Quinones-Hinojosa A: Advances in brain tumor surgery for
glioblastoma in adults. Brain Sci. 7(166)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gaspar LE, Fisher BJ, Macdonald DR, LeBer
DV, Halperin EC, Schold SC Jr and Cairncross JG: Supratentorial
malignant glioma: Patterns of recurrence and implications for
external beam local treatment. Int J Radiat Oncol Biol Phys.
24:55–57. 1992.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang X, Ding K, Wang J, Li X and Zhao P:
Chemoresistance caused by the microenvironment of glioblastoma and
the corresponding solutions. Biomed Pharmacother. 109:39–46.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang M, Wang X, Chen X, Zhang Q and Hong
J: Novel immune-related gene signature for risk stratification and
prognosis of survival in lower-grade glioma. Front Genet.
11(363)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Au-Yeung CL, Yeung TL, Achreja A, Zhao H,
Yip KP, Kwan SY, Onstad M, Sheng J, Zhu Y, Baluya DL, et al: ITLN1
modulates invasive potential and metabolic reprogramming of ovarian
cancer cells in omental microenvironment. Nat Commun.
11(3546)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Erin N, Grahovac J, Brozovic A and Efferth
T: Tumor microenvironment and epithelial mesenchymal transition as
targets to overcome tumor multidrug resistance. Drug Resist Updat.
53(100715)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Uttam S, Stern AM, Sevinsky CJ, Furman S,
Pullara F, Spagnolo D, Nguyen L, Gough A, Ginty F, Lansing Taylor D
and Chakra Chennubhotla S: Spatial domain analysis predicts risk of
colorectal cancer recurrence and infers associated tumor
microenvironment networks. Nat Commun. 11(3515)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang W, Yang S, Zhang F, Cheng F, Wang X
and Rao J: Influence of the Hippo-YAP signalling pathway on tumor
associated macrophages (TAMs) and its implications on cancer
immunosuppressive microenvironment. Ann Transl Med.
8(399)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schiffer D, Annovazzi L, Casalone C,
Corona C and Mellai M: Glioblastoma: Microenvironment and Niche
Concept. Cancers (Basel). 11(5)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hao Q, Vadgama JV and Wang P: CCL2/CCR2
signaling in cancer pathogenesis. Cell Commun Signal.
18(82)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Desbaillets I, Tada M, de Tribolet N,
Diserens AC, Hamou MF and Van Meir EG: Human astrocytomas and
glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in
vivo and in vitro. Int J Cancer. 58:240–247. 1994.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nalla AK, Gogineni VR, Gupta R, Dinh DH
and Rao JS: Suppression of uPA and uPAR blocks radiation-induced
MCP-1 mediated recruitment of endothelial cells in meningioma. Cell
Signal. 23:1299–1310. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fischer S, Weishaupt A, Troppmair J and
Martini R: Increase of MCP-1 (CCL2) in myelin mutant Schwann cells
is mediated by MEK-ERK signaling pathway. Glia. 56:836–843.
2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yoshimura T: The production of monocyte
chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments.
Cytokine. 98:71–78. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vakilian A, Khorramdelazad H, Heidari P,
Sheikh Rezaei Z and Hassanshahi G: CCL2/CCR2 signaling pathway in
glioblastoma multiforme. Neurochem Int. 103:1–7. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
He M, Yu W, Chang C, Miyamoto H, Liu X,
Jiang K and Yeh S: Estrogen receptor α promotes lung cancer cell
invasion via increase of and cross-talk with infiltrated
macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling
pathways. Mol Oncol. 14:1779–1799. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lubos N, van der Gaag S, Gercek M, Kant S,
Leube RE and Krusche CA: Inflammation shapes pathogenesis of murine
arrhythmogenic cardiomyopathy. Basic Res Cardiol.
115(42)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gong X, Duan Y, Zheng J, Ye Z and Hei TK:
Tetramethylpyrazine prevents contrast-induced nephropathy via
modulating tubular cell mitophagy and suppressing mitochondrial
fragmentation, CCL2/CCR2-mediated inflammation, and intestinal
injury. Oxid Med Cell Longev. 2019(7096912)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou W, Jiang Z, Xu YY and Li XG:
Attention to normal brain volumes in glioblastoma radiotherapy:
Potential role in tumor invasion and vasculogenesis. Med
Hypotheses. 80:501–504. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mistry AM, Mummareddy N, Salwi S, Davis LT
and Ihrie RA: Glioblastoma distance from the subventricular neural
stem cell niche does not correlate with survival. Front Oncol.
10(564889)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li N, Li Y, Li Z, Huang C, Yang Y, Lang M,
Cao J, Jiang W, Xu Y, Dong J and Ren H: Hypoxia inducible factor 1
(HIF-1) recruits macrophage to activate pancreatic stellate cells
in pancreatic ductal adenocarcinoma. Int J Mol Sci.
17(799)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang X, Wang J, Li X and Wang D:
Lysosomes contribute to radioresistance in cancer. Cancer Lett.
439:39–46. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cui YH, Suh Y, Lee HJ, Yoo KC, Uddin N,
Jeong YJ, Lee JS, Hwang SG, Nam SY, Kim MJ and Lee SJ: Radiation
promotes invasiveness of non-small-cell lung cancer cells through
granulocyte-colony-stimulating factor. Oncogene. 34:5372–5382.
2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Morganti JM, Jopson TD, Liu S, Gupta N and
Rosi S: Cranial irradiation alters the brain's microenvironment and
permits CCR2+ macrophage infiltration. PLoS One.
9(e93650)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cherry JD, Meng G, Daley S, Xia W, Svirsky
S, Alvarez VE, Nicks R, Pothast M, Kelley H, Huber B, et al: CCL2
is associated with microglia and macrophage recruitment in chronic
traumatic encephalopathy. J Neuroinflammation.
17(370)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yoshimura T: The chemokine MCP-1 (CCL2) in
the host interaction with cancer: A foe or ally? Cell Mol Immunol.
15:335–345. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen Z, Feng X, Herting CJ, Garcia VA, Nie
K, Pong WW, Rasmussen R, Dwivedi B, Seby S, Wolf SA, et al:
Cellular and molecular identity of tumor-associated macrophages in
glioblastoma. Cancer Res. 77:2266–2278. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
He S, He S, Chen CH, Deborde S, Bakst RL,
Chernichenko N, McNamara WF, Lee SY, Barajas F, Yu Z, et al: The
chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
Mol Cancer Res. 13:380–390. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhu X, Fujita M, Snyder LA and Okada H:
Systemic delivery of neutralizing antibody targeting CCL2 for
glioma therapy. J Neurooncol. 104:83–92. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
D'Alessio A, Proietti G, Sica G and
Scicchitano BM: Pathological and molecular features of glioblastoma
and its peritumoral tissue. Cancers (Basel). 11(469)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Seifert M, Schackert G, Temme A, Schröck
E, Deutsch A and Klink B: Molecular characterization of astrocytoma
progression towards secondary glioblastomas utilizing
patient-matched tumor pairs. Cancers (Basel).
12(1696)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Aldape K, Zadeh G, Mansouri S,
Reifenberger G and von Deimling A: Glioblastoma: Pathology,
molecular mechanisms and markers. Acta Neuropathol. 129:829–848.
2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kalbasi A, Komar C, Tooker GM, Liu M, Lee
JW, Gladney WL, Ben-Josef E and Beatty GL: Tumor-derived CCL2
mediates resistance to radiotherapy in pancreatic ductal
adenocarcinoma. Clin Cancer Res. 23:137–148. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Thomas JG, Parker Kerrigan BC, Hossain A,
Gumin J, Shinojima N, Nwajei F, Ezhilarasan R, Love P, Sulman EP
and Lang FF: Ionizing radiation augments glioma tropism of
mesenchymal stem cells. J Neurosurg. 128:287–295. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Flores-Toro JA, Luo D, Gopinath A,
Sarkisian MR, Campbell JJ, Charo IF, Singh R, Schall TJ, Datta M,
Jain RK, et al: CCR2 inhibition reduces tumor myeloid cells and
unmasks a checkpoint inhibitor effect to slow progression of
resistant murine gliomas. Proc Natl Acad Sci USA. 117:1129–1138.
2020.PubMed/NCBI View Article : Google Scholar
|
